Imidazolidines
- Name
- Imidazolidines
- Accession Number
- DBCAT000613
- Description
Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.
- Drugs
Drug Drug Description Phenytoin An anticonvulsant drug used in the prophylaxis and control of various types of seizures. Enzalutamide A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. Apalutamide An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. Ethotoin A hydantoin antiepileptic used to control tonic-clonic and complex partial seizures. Azimilide Investigated for use/treatment in arrhythmia and atrial fibrillation. Allantoin An ingredient used in skin care products to relieve irritation and protect minor cuts, scrapes, and burns. AZD-1236 AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. GLPG-0492 Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492). Clodantoin Not Annotated Mephenytoin A phenylhydantoin used to treat refractory partial epilepsy. Dantrolene A direct-acting skeletal muscle relaxant used for the treatment of management of the fulminant hypermetabolism of skeletal muscle leading to malignant hyperthermia crisis. Fosphenytoin An antiepileptic agent used for the management of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Proxalutamide Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer). - Drugs & Drug Targets